re: Ann: Appendix 3Y - Change of Director'... Director starts to see value @ current level? Hopefully this marks the iron bottom of MTE.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%